Drug Profile
Cyclobenzaprine/meloxicam - Eurofarma
Alternative Names: Meloxicam/cyclobenzaprine - EurofarmaLatest Information Update: 13 May 2016
Price :
$50
*
At a glance
- Originator Eurofarma
- Class Analgesics; Antipyretics; Antirheumatics; Dibenzocycloheptenes; Muscle relaxants; Nonsteroidal anti-inflammatories; Thiazines; Thiazoles
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Back pain
Most Recent Events
- 13 May 2016 Discontinued - Preclinical for Back pain in Brazil (PO)
- 13 May 2016 Eurofarma withdraws a phase III trial for Back pain prior to enrolment in Brazil (NCT01587508)
- 24 Apr 2012 Preclinical trials in Back pain in Brazil (PO)